Squamous cell carcinoma
|
0.030 |
AlteredExpression
|
disease |
LHGDN |
Growth-regulated oncogene-1 expression is associated with angiogenesis and lymph node metastasis in human oral cancer.
|
15218300 |
2004 |
Malignant neoplasm of mouth
|
0.030 |
AlteredExpression
|
group |
BEFREE |
A previous article noted that GRO-1 was upregulated in oral cancer using a genome-wide microarray approach.
|
15218300 |
2004 |
Lip and Oral Cavity Carcinoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
A previous article noted that GRO-1 was upregulated in oral cancer using a genome-wide microarray approach.
|
15218300 |
2004 |
Neoplasm Metastasis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
We previously performed gene expression profiling in a multistep squamous cell carcinoma (SCC) progression model, and identified growth-regulated oncogene-1 (Gro-1/KC) as a factor that contributes to enhanced angiogenesis, tumorigenesis and metastasis.
|
15221009 |
2004 |
Tumor Angiogenesis
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
We previously performed gene expression profiling in a multistep squamous cell carcinoma (SCC) progression model, and identified growth-regulated oncogene-1 (Gro-1/KC) as a factor that contributes to enhanced angiogenesis, tumorigenesis and metastasis.
|
15221009 |
2004 |
Squamous cell carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
We previously performed gene expression profiling in a multistep squamous cell carcinoma (SCC) progression model, and identified growth-regulated oncogene-1 (Gro-1/KC) as a factor that contributes to enhanced angiogenesis, tumorigenesis and metastasis.
|
15221009 |
2004 |
Neoplasm Metastasis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
These included growth regulated oncogene alpha (GROalpha/GRO1/CXCL1), another neutrophil chemoattractant implicated in tumor angiogenesis and metastasis.
|
15256456 |
2004 |
Tumor Angiogenesis
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
These included growth regulated oncogene alpha (GROalpha/GRO1/CXCL1), another neutrophil chemoattractant implicated in tumor angiogenesis and metastasis.
|
15256456 |
2004 |
Dermatologic disorders
|
0.020 |
Biomarker
|
group |
LHGDN |
The lesional skin of linear IgA bullous dermatosis expresses growth-regulated peptide (GRO)-alpha.
|
15492419 |
2004 |
Colon Carcinoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
These data demonstrate that the constitutive expression of CXCL1 and its receptor CXCR2 is associated with metastatic potential and modulates colon cancer cell proliferation and an invasive phenotype.
|
15787094 |
2004 |
Malignant tumor of colon
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
These data demonstrate that the constitutive expression of CXCL1 and its receptor CXCR2 is associated with metastatic potential and modulates colon cancer cell proliferation and an invasive phenotype.
|
15787094 |
2004 |
Metastatic Colon Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Non-metastatic and low metastatic cells expressed lower levels of CXCL1 and CXCR2 mRNA and protein as compared to high metastatic colon carcinoma cells.
|
15787094 |
2004 |
Alzheimer's Disease
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Therefore, the data presented here suggests that the CXCL1 gene could not be associated with the susceptibility to AD in a Japanese population.
|
15843053 |
2005 |
melanoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
In addition, the melanoma growth and migration stimulatory chemokines CXCL1 and CXCL2 were significantly up-regulated in the cocultured fibroblasts.
|
15899804 |
2005 |
Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
Three markers, heat shock protein 70 (HSP-70), chemokine (C-X-C motif) ligand 1 (CXCL-1), and secreted leukocyte protease inhibitor (SLPI), were studied further with breast cancer tissue microarrays using a novel method of automated quantitative analysis.
|
15994930 |
2005 |
Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Three markers, heat shock protein 70 (HSP-70), chemokine (C-X-C motif) ligand 1 (CXCL-1), and secreted leukocyte protease inhibitor (SLPI), were studied further with breast cancer tissue microarrays using a novel method of automated quantitative analysis.
|
15994930 |
2005 |
melanoma
|
0.100 |
Biomarker
|
disease |
LHGDN |
As determined by ELISA, endothelin-1 (ET-1) induces CXCL1 and CXCL8 secretion in three human melanoma cell lines in a concentration-dependent fashion.
|
16098041 |
2005 |
Hepatitis, Toxic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils.
|
16118408 |
2005 |
Drug-Induced Liver Disease
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils.
|
16118408 |
2005 |
Hepatitis, Drug-Induced
|
0.300 |
Biomarker
|
disease |
CTD_human |
Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils.
|
16118408 |
2005 |
Drug-Induced Acute Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils.
|
16118408 |
2005 |
Chemical and Drug Induced Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils.
|
16118408 |
2005 |
Chemically-Induced Liver Toxicity
|
0.300 |
Biomarker
|
disease |
CTD_human |
Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils.
|
16118408 |
2005 |
melanoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Another protein, m/z 7,866, was identified as CXC chemokine ligand 1 (CXCL1) or GRO-alpha, a chemokine associated with melanoma formation and some epithelial cancers.
|
16452192 |
2006 |
Reperfusion Injury
|
0.500 |
Biomarker
|
disease |
CTD_human |
Effect of furosemide infusion on renal hemodynamics and angiogenesis gene expression in acute renal ischemia/reperfusion.
|
16526316 |
2006 |